234 related articles for article (PubMed ID: 2292136)
1. Autocrine regulation of cell growth and transformation by basic fibroblast growth factor.
Yayon A; Klagsbrun M
Cancer Metastasis Rev; 1990 Nov; 9(3):191-202. PubMed ID: 2292136
[TBL] [Abstract][Full Text] [Related]
2. Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.
Moscatelli D; Quarto N
J Cell Biol; 1989 Nov; 109(5):2519-27. PubMed ID: 2553749
[TBL] [Abstract][Full Text] [Related]
3. Autocrine transformation by chimeric signal peptide-basic fibroblast growth factor: reversal by suramin.
Yayon A; Klagsbrun M
Proc Natl Acad Sci U S A; 1990 Jul; 87(14):5346-50. PubMed ID: 2164679
[TBL] [Abstract][Full Text] [Related]
4. Transformation by basic fibroblast growth factor requires high levels of expression: comparison with transformation by hst/K-fgf.
Quarto N; Talarico D; Sommer A; Florkiewicz R; Basilico C; Rifkin DB
Oncogene Res; 1989; 5(2):101-10. PubMed ID: 2608276
[TBL] [Abstract][Full Text] [Related]
5. The K-fgf/hst oncogene induces transformation through an autocrine mechanism that requires extracellular stimulation of the mitogenic pathway.
Talarico D; Basilico C
Mol Cell Biol; 1991 Feb; 11(2):1138-45. PubMed ID: 1990270
[TBL] [Abstract][Full Text] [Related]
6. Differential modulation of cell phenotype by different molecular weight forms of basic fibroblast growth factor: possible intracellular signaling by the high molecular weight forms.
Bikfalvi A; Klein S; Pintucci G; Quarto N; Mignatti P; Rifkin DB
J Cell Biol; 1995 Apr; 129(1):233-43. PubMed ID: 7698988
[TBL] [Abstract][Full Text] [Related]
7. The fibroblast growth factor family: structural and biological properties.
Klagsbrun M
Prog Growth Factor Res; 1989; 1(4):207-35. PubMed ID: 2491263
[TBL] [Abstract][Full Text] [Related]
8. Characterization of tumors produced by signal peptide-basic fibroblast growth factor-transformed cells.
Rogelj S; Weinberg RA; Fanning P; Klagsbrun M
J Cell Biochem; 1989 Jan; 39(1):13-23. PubMed ID: 2469690
[TBL] [Abstract][Full Text] [Related]
9. Histidine-rich glycoprotein and platelet factor 4 mask heparan sulfate proteoglycans recognized by acidic and basic fibroblast growth factor.
Brown KJ; Parish CR
Biochemistry; 1994 Nov; 33(46):13918-27. PubMed ID: 7524669
[TBL] [Abstract][Full Text] [Related]
10. Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.
Song S; Wientjes MG; Gan Y; Au JL
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8658-63. PubMed ID: 10890892
[TBL] [Abstract][Full Text] [Related]
11. Culture-induced increase in acidic and basic fibroblast growth factor activities and their association with the nuclei of vascular endothelial and smooth muscle cells.
Speir E; Sasse J; Shrivastav S; Casscells W
J Cell Physiol; 1991 May; 147(2):362-73. PubMed ID: 1710230
[TBL] [Abstract][Full Text] [Related]
12. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1.
Forough R; Xi Z; MacPhee M; Friedman S; Engleka KA; Sayers T; Wiltrout RH; Maciag T
J Biol Chem; 1993 Feb; 268(4):2960-8. PubMed ID: 7679105
[TBL] [Abstract][Full Text] [Related]
13. Low level expression of basic FGF upregulates Bcl-2 and delays apoptosis, but high intracellular levels are required to induce transformation in NIH 3T3 cells.
Wieder R; Wang H; Shirke S; Wang Q; Menzel T; Feirt N; Jakubowski AA; Gabrilove JL
Growth Factors; 1997; 15(1):41-60. PubMed ID: 9401817
[TBL] [Abstract][Full Text] [Related]
14. Possible activity of acidic fibroblast growth factor as a progression factor rather than a transforming factor.
Takahashi JB; Hoshimaru M; Jaye M; Kikuchi H; Hatanaka M
Biochem Biophys Res Commun; 1992 Nov; 189(1):398-405. PubMed ID: 1280423
[TBL] [Abstract][Full Text] [Related]
15. Effects of acidic and basic fibroblast growth factors (aFGF, bFGF) on glial precursor cell proliferation: age dependency and brain region specificity.
Engele J; Bohn MC
Dev Biol; 1992 Aug; 152(2):363-72. PubMed ID: 1379560
[TBL] [Abstract][Full Text] [Related]
16. Suppression of autocrine cell proliferation and tumorigenesis of human melanoma cells and fibroblast growth factor transformed fibroblasts by a kinase-deficient FGF receptor 1: evidence for the involvement of Src-family kinases.
Yayon A; Ma YS; Safran M; Klagsbrun M; Halaban R
Oncogene; 1997 Jun; 14(25):2999-3009. PubMed ID: 9223663
[TBL] [Abstract][Full Text] [Related]
17. Autocrine transformation by fibroblast growth factor 9 (FGF-9) and its possible participation in human oncogenesis.
Matsumoto-Yoshitomi S; Habashita J; Nomura C; Kuroshima K; Kurokawa T
Int J Cancer; 1997 May; 71(3):442-50. PubMed ID: 9139882
[TBL] [Abstract][Full Text] [Related]
18. Regulation of adipocyte precursor DNA synthesis by acidic and basic fibroblast growth factors: interaction with heparin and other growth factors.
Butterwith SC; Peddie CD; Goddard C
J Endocrinol; 1993 Jun; 137(3):369-74. PubMed ID: 7690390
[TBL] [Abstract][Full Text] [Related]
19. Expression of two different forms of fibroblast growth factor receptor 1 in different mouse tissues and cell lines.
Bernard O; Li M; Reid HH
Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7625-9. PubMed ID: 1715572
[TBL] [Abstract][Full Text] [Related]
20. Activation of a transfected FGFR-1 receptor in Madin-Darby epithelial cells results in a reversible loss of epithelial properties.
Migdal M; Soker S; Yarden Y; Neufeld G
J Cell Physiol; 1995 Feb; 162(2):266-76. PubMed ID: 7529769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
